Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Craig Martens

Showing results (81-90 of 112) with videos related to

Pageof 12
Sort By:
The Journal of Infectious Diseases|March 27, 2018
Characterization of the Neutralizing Antibody Response in a Case of Genetically Linked HIV SuperinfectionDeogratius Ssemwanga, Nicole A Doria-Rose, Andrew D Redd, et al.
Npj Viruses|April 28, 2025
Jamaican fruit bat (Artibeus jamaicensis) insusceptibility to mucosal inoculation with SARS-CoV-2 Delta variant is not caused by receptor compatibilityJulia R Port, Jade C Riopelle, Sarah van Tol, et al.
The Journal of Infectious Diseases|October 4, 2019
Longitudinal Antibody Responses in People Who Inject Drugs Infected With Similar Human Immunodeficiency Virus StrainsAndrew D Redd, Nicole A Doria-Rose, Joshua A Weiner, et al.
Biorxiv : the Preprint Server for Biology|January 15, 2021
Intranasal ChAdOx1 nCoV-19/AZD1222 vaccination reduces shedding of SARS-CoV-2 D614G in rhesus macaquesNeeltje van Doremalen, Jyothi N Purushotham, Jonathan E Schulz, et al.
Nature Communications|October 8, 2021
ChAdOx1 nCoV-19 (AZD1222) protects Syrian hamsters against SARS-CoV-2 B.1.351 and B.1.1.7Robert J Fischer, Neeltje van Doremalen, Danielle R Adney, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|May 28, 2016
Simtuzumab treatment of advanced liver fibrosis in HIV and HCV-infected adults: results of a 6-month open-label safety trialEric G Meissner, Mary McLaughlin, Lindsay Matthews, et al.
Science Translational Medicine|July 28, 2021
Intranasal ChAdOx1 nCoV-19/AZD1222 vaccination reduces viral shedding after SARS-CoV-2 D614G challenge in preclinical modelsNeeltje van Doremalen, Jyothi N Purushotham, Jonathan E Schulz, et al.
The Journal of Infectious Diseases|September 22, 2012
Previously transmitted HIV-1 strains are preferentially selected during subsequent sexual transmissionsAndrew D Redd, Aleisha N Collinson-Streng, Nikolaos Chatziandreou, et al.
Biorxiv : the Preprint Server for Biology|March 24, 2021
ChAdOx1 nCoV-19 (AZD1222) protects Syrian hamsters against SARS-CoV-2 B.1.351 and B.1.1.7Robert J Fischer, Neeltje van Doremalen, Danielle R Adney, et al.
The Journal of Infectious Diseases|January 7, 2026
Estimating HIV-1 Viremic Time from Reservoir Sequence Diversity with Uncertainty QuantificationEdward N Kankaka, Stephen Tomusange, Taddeo Kityamuweesi, et al.
Pageof 12

Showing results (81-90 of 112) with videos related to

Sort By:
Pageof 12
The Journal of Infectious Diseases|March 27, 2018
Characterization of the Neutralizing Antibody Response in a Case of Genetically Linked HIV SuperinfectionDeogratius Ssemwanga, Nicole A Doria-Rose, Andrew D Redd, et al.
Npj Viruses|April 28, 2025
Jamaican fruit bat (Artibeus jamaicensis) insusceptibility to mucosal inoculation with SARS-CoV-2 Delta variant is not caused by receptor compatibilityJulia R Port, Jade C Riopelle, Sarah van Tol, et al.
The Journal of Infectious Diseases|October 4, 2019
Longitudinal Antibody Responses in People Who Inject Drugs Infected With Similar Human Immunodeficiency Virus StrainsAndrew D Redd, Nicole A Doria-Rose, Joshua A Weiner, et al.
Biorxiv : the Preprint Server for Biology|January 15, 2021
Intranasal ChAdOx1 nCoV-19/AZD1222 vaccination reduces shedding of SARS-CoV-2 D614G in rhesus macaquesNeeltje van Doremalen, Jyothi N Purushotham, Jonathan E Schulz, et al.
Nature Communications|October 8, 2021
ChAdOx1 nCoV-19 (AZD1222) protects Syrian hamsters against SARS-CoV-2 B.1.351 and B.1.1.7Robert J Fischer, Neeltje van Doremalen, Danielle R Adney, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|May 28, 2016
Simtuzumab treatment of advanced liver fibrosis in HIV and HCV-infected adults: results of a 6-month open-label safety trialEric G Meissner, Mary McLaughlin, Lindsay Matthews, et al.
Science Translational Medicine|July 28, 2021
Intranasal ChAdOx1 nCoV-19/AZD1222 vaccination reduces viral shedding after SARS-CoV-2 D614G challenge in preclinical modelsNeeltje van Doremalen, Jyothi N Purushotham, Jonathan E Schulz, et al.
The Journal of Infectious Diseases|September 22, 2012
Previously transmitted HIV-1 strains are preferentially selected during subsequent sexual transmissionsAndrew D Redd, Aleisha N Collinson-Streng, Nikolaos Chatziandreou, et al.
Biorxiv : the Preprint Server for Biology|March 24, 2021
ChAdOx1 nCoV-19 (AZD1222) protects Syrian hamsters against SARS-CoV-2 B.1.351 and B.1.1.7Robert J Fischer, Neeltje van Doremalen, Danielle R Adney, et al.
The Journal of Infectious Diseases|January 7, 2026
Estimating HIV-1 Viremic Time from Reservoir Sequence Diversity with Uncertainty QuantificationEdward N Kankaka, Stephen Tomusange, Taddeo Kityamuweesi, et al.
Pageof 12